Dr. Stephen Dolan and Ph.D. student Jessica Aycock and undergraduate Mallory Murphy spent three days at the North American Cystic Fibrosis Conference (NACFC) in Boston, MA presenting their research and divulging in CF research from other academics and clinicians.
NACFC is amazing learning experience and opportunity to collaborate with other CF researchers. Both Jessica and Mallory received grants to attend this conference – Jessica was funded by the National Institutes of Health and the Cystic Fibrosis Foundation and Mallory was funded by a Seifert Scholarship.
Mallory and Jessica presented their research at the poster forum alongside other CF researchers and clinicians, while Dr. Dolan served as the co-chair and panelist of the “Fungal Infections in CF” session.
The title of Jessica’s research poster was “Pseudomonas aeruginosa detects fungal toxins using a novel regulatory cascade.”
The title of Mallory’s research poster was “Exploring the diversity and function of the RTA1-like protein family in Aspergillus fumigatus.”
Senior biochemistry major Adam Gatch is many things: a student, a hiker, a researcher, a tutor, a Goldwater Scholar, an EMT, a volunteer, a writer, a backpacker – too many things to name.
Originally from Charleston, SC, Adam enjoys Clemson for its people and its proximity to great hiking spots and the mountains.
“It’s been nice to meet others with strong work ethic and passion for learning, and it has been motivating to be surrounded by other students with all kinds of exciting future plans.”
Being involved in many extracurricular activities, Adam’s main focus is his research work with Dr. Feng Ding, who runs the Clemson Multiscale Biophysics Lab in the Department of Physics and Astronomy. With Dr. Ding, he has worked on numerous independent projects investigating the structure and dynamics of various proteins implicated in neurodegenerative disease.
“The major theme of my personal research work is understanding the molecular basis of co-pathologies involving multiple disease-associated proteins. Essentially, many neurodegenerative diseases such as Alzheimer’s and Parkinson’s are characterized by the abnormal accumulation of certain proteins, and the inclusions they form are considered disease hallmarks.”
In some cases, multiple “hallmark” proteins are found in the same pathological assembly or in closely associated assemblies of each protein. Adam’s work seeks to elucidate the molecular mechanisms that enable the proteins to interact and give rise to these co-pathologies, and additionally to understand how that interaction can affect clinical presentation and disease outcome.
Adam’s research experience doesn’t stop there; he is involved in the Clemson University Clinical Undergraduate Research Experiences in Surgery (CURES) and has shadowed neurologists at MUSC. Also, he is involved in the Drug Design, Development, and Delivery (4D) lab led by Dr. Jeoung Soo Lee in the Department of Bioengineering, which is focused on nanoparticle-based therapeutics for traumatic brain injury and spinal cord injury.
“In contrast to my computational biophysics research, the 4D lab utilizes in vivo and in vitro experiments, using rats to study the effectiveness of the treatments developed by the group. While Dr. Ding’s lab appealed to me because of my strong interest in neurodegeneration and molecular-level study of disease, Dr. Lee’s lab was perfect for exploring another clinical interest of mine, namely traumatic brain injury.”
“In my [EMT] work, I have cared for many patients with highly advanced forms of neurodegenerative disease, which reinforces my motivation to study these diseases in the lab. These experiences have been hugely impactful in affirming my commitment to my future career as a physician-scientist.”
After graduation Adam plans to take a couple gap years traveling around Europe before applying to a number of MD-Ph.D. programs in neuroscience. Afterward, he plans to complete medical residency in neurosurgery and lead a research-intensive career as an academic neurosurgeon at a medical university.
“I plan to continue working on highly interdisciplinary research throughout my Ph.D. training and later in my career, hope to one day lead a successful lab.”
Jessica Aycock is a second year Ph.D. student in Dr. Stephen Dolan’s lab housed in the Eukaryotic Pathogens Innovation Center (EPIC) at Clemson University. This fall she had the opportunity to intern at IDeA National Resource for Quantitative Proteomics at the Winthrop P. Rockefeller Cancer Institute at University of Arkansas for Medical Sciences (UAMS) in Little Rock, AK.
The IDeA National Resource for Quantitative Proteomics Internship program is designed to provide a unique opportunity for the next generation of scientists to explore an alternative career option in biomedical research by gaining experience in a national resource and core facility environment. Interns are encouraged to bring proteomics samples related to their project, enabling them to work on their own research while they are interning.
Jessica spent two weeks at IDeA National Resource for Quantitative Proteomics gaining a unique hands-on research experience which included managing the entire behind the scenes proteomics workflow – sample prep, mass spectrometry and downstream bioinformatics processing – on her own Ph.D. research samples.
“Not only did I deepen my understanding of my own research, but the experience also broadened my perspective of career opportunities beyond traditional paths.”
In addition, Jessica learned the ins and outs of mass spectrometers including instrumentation, operation and contribution to data acquisition. She also had the chance to explore career options outside of industry and academia, learning how a national core facility functions.
“Learning the intricacies of proteomics through participating in the IDeA National Resource for Quantitative Proteomics internship was an amazing, eye-opening experience. Moving forward, I plan to use these insights to advance my research in the Dolan Lab and explore new directions in the field of proteomics!”
IDeA National Resource for Quantitative Proteomics provides unmatched and cost-effective access to state-of-the-art quantitative proteomics platforms and education, outreach and training opportunities that will increase the capacity of National Institutes of Health-funded investigators to perform cutting-edge biomedical research.
